Company overview
Basic information
Company name
Alpen Pharma, UAB
Company code
305558962
VAT code
LT100013183715
Registered address
Vilnius, Lvivo g. 7-8, LT-09313
Registration date
2020-05-26
Company age: 6 y. 5 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
https://alpenpharma.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Business and other management consultancy activities
Sector
Užsienio subjektų kontroliuojamos ne finansų bendrovės
Ownership form
Private foreign capital
UAB Alpen Pharma
Company code: 305558962
Address: Vilnius, Lvivo g. 7-8, LT-09313
VAT code: LT100013183715
Description
This description was generated by artificial intelligence.
Alpen Pharma, UAB (company code 305558962) is a private limited liability company registered in 2020 and currently operational. The company is classified as a micro-sized private business in the sector of non-financial companies controlled by foreign entities, with private ownership where foreign natural and legal persons hold more than 50% of the authorised capital. Its governance structure is listed as CEO with board/council. The company is based in Vilnius, at Lvivo g. 7-8, in Vilniaus m. sav. and Vilniaus apskr. Its main activity is under EVRK code N.70.20.00, Business and other management consultancy activities. The share capital is €150.0K.
In financial year 2025, Alpen Pharma generated revenue of €1.24M and net profit of €53.9K, with a profit margin of 4.4%. Revenue increased by 13.5% year on year and by 24.7% over two years. At year-end 2025, equity stood at €249.7K, liabilities at €85.0K, and total assets at €334.7K. The company employed 5 people on average so far in 2026, up from 4 in 2025, and the average monthly wage was €3,817.52 so far in 2026. Estimated annual payroll for the latest staff year was €229.1K.
In financial year 2025, Alpen Pharma generated revenue of €1.24M and net profit of €53.9K, with a profit margin of 4.4%. Revenue increased by 13.5% year on year and by 24.7% over two years. At year-end 2025, equity stood at €249.7K, liabilities at €85.0K, and total assets at €334.7K. The company employed 5 people on average so far in 2026, up from 4 in 2025, and the average monthly wage was €3,817.52 so far in 2026. Estimated annual payroll for the latest staff year was €229.1K.
Download a detailed company report
Make confident decisions with all the information about Alpen Pharma, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.